• (+5411) 3965-8409
  • This email address is being protected from spambots. You need JavaScript enabled to view it.

COVID-19

COVID-19 active studies

  • A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Assess the Efficacy and Safety of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults Aged 18 Years and Older.

  • CoVPN 5001 Protocol: Prospective study of acute immune responses to SARS-CoV-2 infection.

  • International Observational Study of Outpatients with SARS-CoV-2 Infection.

  • Randomized double-blind, placebo-controlled clinical trial of convalescent plasma in the treatment of COVID-19 pneumonia with severity criteria.

  • SARS-CoV-2 testing and incidence of COVID-19 in asymptomatic health workers from two Hospitals in the Metropolitan Area of Buenos Aires.

  • Telemedicine in HIV care in public hospitals in Buenos Aires during the COVID-19 pandemic: implementation study.

  • Cohort study on the Incidence of symptomatic COVID 19 infection and its risk factors for morbidity and mortality in patients with HIV infection.

CICAL

Urquiza 358, Balvanera (CP 1215).
Ciudad Autónoma de Buenos Aires, Argentina

Tel.: (+5411) 3965-8409

A nonprofit project of

Contact

© 2022 CICAL. Todos los derechos reservados.